Bottom line
What is DEMAX's expense ratio?
DEMAX's expense ratio is 1.4%, or about $140 a year on every $10,000 invested. That is more expensive than 79% of emerging markets funds we track (median 1.02%). This share class also charges a front-end sales load of up to 5.75%, taken from your investment when you buy. Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Mar 27, 2026
DEMAX fee table
| Net expense ratio | 1.4% |
|---|---|
| Gross expense ratio | 1.57% |
| Management fee | 1.13% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0.19% |
| Fee waiver / reimbursement | -0.17% |
| Max front-end sales load | 5.75% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Mar 27, 2026
What DEMAX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| DEMAX | $709 | $1,027 | $1,366 | $2,321 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.4% expense ratio costs roughly $74,900 in lost growth, versus about $56,400 for the median emerging markets fund (1.02%).